Human papilloma virus and molluscum contagiosum lesions related to infliximab therapy for psoriasis: A case series

Dermatology Online Journal

Volumn 18, Issue 4, 2012, Pages 9-

  Georgala, S ^a   Katoulis, A C ^b   Kanelleas, A ^a   Befon, A ^a   Georgala, C ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; EMOLLIENT AGENT; INFLIXIMAB; METHOTREXATE; ANTIINFLAMMATORY AGENT; MONOCLONAL ANTIBODY;

ABDOMEN; ADULT; ANUS; CASE REPORT; CONDYLOMA ACUMINATUM; CRYOTHERAPY; DRUG WITHDRAWAL; FEMALE; GENITAL SYSTEM; HUMAN; LETTER; LIP; MALE; MOLLUSCUM CONTAGIOSUM; NOSE; PAPILLOMAVIRUS INFECTION; PSORIASIS; IMMUNOLOGY; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; IMMUNOMODULATION; IMMUNOSUPPRESSION; MALE; MOLLUSCUM CONTAGIOSUM; PAPILLOMAVIRUS INFECTIONS; PSORIASIS; YOUNG ADULT;

EID: 84864417900     PISSN: 10872108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (18)

1. Tracey D, Lareskog L, Sasso E, et al. Tumour necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther 2008; 117: 244-79.[PubMed]
2. Wilson NJ, Boniface K, Chan JR, et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nature Immunol 2007; 8: 950-7.[PubMed]
3. Blauvelt A. T-helper 17 cells in psoriatic plaques and additional genetic links between IL-23 and psoriasis. J Invest Dermatol 2008; 128: 1064-7.[PubMed]
4. Panthirana D, Ormerod AD, Saiag P, et al. European S3-Guidelines on the systemic treatment of psoriasis vulgaris. J Europ Acad Dermatol Venereol 2009; 23 (suppl 2): S5-70. [PubMed]
5. Rosenberg EW, Yusk JW. Molluscum contagiosum. Eruption following treatment with prednisone and methotrexate. Arch Dermatol 1970; 101: 439-41.[PubMed]
6. Cotton DW, Cooper C, Barrett DF, et al. Severe atypical molluscum contagiosum infection in an immunocompromised host. Br J Dermatol 1987; 116: 871-6. [PubMed]
7. Antoniou C, Kosmadaki MG, Stratigos AJ, et al. Genital HPV lesions and molluscum contagiosum occurring in patients receiving anti-TNF-alpha therapy. Dermatology 2008; 216: 364-5.[PubMed]
8. Euvrard S, Kanitakis J, Cochat P, et al. Skin diseases in children with organ transplants. J Am Acad Dermatol 2001; 44: 932-9.[PubMed]
9. Gentile G, Formelli G, Orsoni G, et al. Immunosuppression and human genital papillomavirus infection. Eur J Gynaecol Oncol 1991; 12: 79-81.[PubMed]
10. Rudlinger R, Grob R, Buchmann P, et al. Anogenital warts of the condyloma acuminatum type in HIV-positive patients. Dermatologica 1988; 176: 277-81. [PubMed]
11. Morison WL. Viral warts, herpes simplex and herpes zoster in patients with secondary immune deficiencies and neoplasms. Br J Dermatol 1975; 92: 625-30[PubMed]
12. Herrero R. Human papillomavirus and cancer of the upper aerodigestive tract. J Natl Cancer Inst Monogr. 2003; 31: 47-51.[PubMed]
13. Fillipova M., Song H., Connolly JL., et al. The human papillomavirus 16 E16 protein binds to tumor necrosis factor receptor (TNF) R1 and protects cells from TNF-induced apoptosis. J Biol Chem 2002; 277: 21730-9.[PubMed]
14. Hu S., Vincenz C., Buller M., et al.: A novel family of viral death effector domain-containing molecules that inhibit both CD-95- and tumor necrosis factor receptor-1-induced apoptosis. J Biol Chem 1997; 272: 9621-4.[PubMed]
15. Kane S, Khatibi B, Reddy D. Higher incidence of abnormal pap smears in women with inflammatory bowel disease. Am J Gastroenterol 2008; 103: 631-63.[PubMed]
16. Singh H, Demers AA, Nugent Z, et al. Risk of cervical abnormalities in women with inflammatory bowel disease: a population-based nested case control study. Gastroenterology 2009; 136: 451-8.[PubMed]
17. Fireman B, Kane S, Herrinton LJ. Screening differences and risk of cervical cancer in inflammatory bowel disease. Aliment Pharmacol Ther 2008; 28: 598-605.[PubMed]
18. Somasekar A, Alcolado R. Genital condylomata in a patient receiving infliximab for Crohn's disease. Postgrad Med J 2004; 80: 358-9.[PubMed]